[
    {
        "data": {
            "entities": {
                "urls": [
                    {
                        "start": 203,
                        "end": 226,
                        "url": "https://t.co/WjR5yhrNdn",
                        "expanded_url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00528-6/fulltext#:~:text=Supporting%20a%20longer%2Dinterval%20immunisation,was%20significantly%20higher%20at%2081&text=3%25%20(60&text=3%E2%80%9391&text=2)%20after%20two%20standard%20doses,or%20longer%2C%20compared%20with%2055",
                        "display_url": "thelancet.com/journals/lance\u2026",
                        "images": [
                            {
                                "url": "https://pbs.twimg.com/news_img/1454565484016201729/xl4VQcyz?format=jpg&name=orig",
                                "width": 181,
                                "height": 262
                            },
                            {
                                "url": "https://pbs.twimg.com/news_img/1454565484016201729/xl4VQcyz?format=jpg&name=150x150",
                                "width": 150,
                                "height": 150
                            }
                        ],
                        "status": 200,
                        "title": "Single-dose Oxford\u2013AstraZeneca COVID-19 vaccine followed by a 12-week booster",
                        "description": "Vaccines to prevent COVID-19 infection are crucial for an effective global pandemic response. In The Lancet, Merryn Voysey and colleagues1 report the updated primary efficacy results for the Oxford\u2013AstraZeneca ChAdOx1 nCoV-19 (AZD1222) vaccine from three single-blind, randomised controlled trials in the UK and Brazil and one double-blind study in South Africa.2\u20134 The ChAdOx1 nCoV-19 vaccine was granted emergency use authorisation in adults by the UK Medicines and Healthcare products Regulatory Agency5 in December, 2020.",
                        "unwound_url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00528-6/fulltext#:~:text=Supporting%20a%20longer%2Dinterval%20immunisation,was%20significantly%20higher%20at%2081&text=3%25%20(60&text=3%E2%80%9391&text=2)%20after%20two%20standard%20doses,or%20longer%2C%20compared%20with%2055"
                    },
                    {
                        "start": 227,
                        "end": 250,
                        "url": "https://t.co/VDPC83vHuQ",
                        "expanded_url": "https://twitter.com/rupasubramanya/status/1396503735107559425",
                        "display_url": "twitter.com/rupasubramanya\u2026"
                    }
                ],
                "annotations": [
                    {
                        "start": 42,
                        "end": 43,
                        "probability": 0.5203,
                        "type": "Place",
                        "normalized_text": "AZ"
                    }
                ]
            },
            "id": "1396771068329799680",
            "context_annotations": [
                {
                    "domain": {
                        "id": "123",
                        "name": "Ongoing News Story",
                        "description": "Ongoing News Stories like 'Brexit'"
                    },
                    "entity": {
                        "id": "1220701888179359745",
                        "name": "COVID-19"
                    }
                },
                {
                    "domain": {
                        "id": "45",
                        "name": "Brand Vertical",
                        "description": "Top level entities that describe a Brands industry"
                    },
                    "entity": {
                        "id": "781974596740190208",
                        "name": "CPG"
                    }
                },
                {
                    "domain": {
                        "id": "46",
                        "name": "Brand Category",
                        "description": "Categories within Brand Verticals that narrow down the scope of Brands"
                    },
                    "entity": {
                        "id": "781974596752773120",
                        "name": "Pharma"
                    }
                },
                {
                    "domain": {
                        "id": "47",
                        "name": "Brand",
                        "description": "Brands and Companies"
                    },
                    "entity": {
                        "id": "10032761422",
                        "name": "Pfizer"
                    }
                }
            ],
            "public_metrics": {
                "retweet_count": 0,
                "reply_count": 1,
                "like_count": 0,
                "quote_count": 0
            },
            "created_at": "2021-05-24T10:12:28.000Z",
            "reply_settings": "everyone",
            "author_id": "749437358",
            "source": "Twitter Web App",
            "text": "This is very misleading. The efficacy for AZ was 60% when the booster dose was given 28 days after the first dose. If the interval is increased to 12 weeks the efficacy is 80% as published March 21 here https://t.co/WjR5yhrNdn https://t.co/VDPC83vHuQ",
            "referenced_tweets": [
                {
                    "type": "quoted",
                    "id": "1396503735107559425"
                }
            ],
            "lang": "en",
            "possibly_sensitive": false,
            "conversation_id": "1396771068329799680"
        },
        "id": 1396771068329799680,
        "text": "This is very misleading. The efficacy for AZ was 60% when the booster dose was given 28 days after the first dose. If the interval is increased to 12 weeks the efficacy is 80% as published March 21 here https://t.co/WjR5yhrNdn https://t.co/VDPC83vHuQ",
        "attachments": null,
        "author_id": 749437358,
        "context_annotations": [
            {
                "domain": {
                    "id": "123",
                    "name": "Ongoing News Story",
                    "description": "Ongoing News Stories like 'Brexit'"
                },
                "entity": {
                    "id": "1220701888179359745",
                    "name": "COVID-19"
                }
            },
            {
                "domain": {
                    "id": "45",
                    "name": "Brand Vertical",
                    "description": "Top level entities that describe a Brands industry"
                },
                "entity": {
                    "id": "781974596740190208",
                    "name": "CPG"
                }
            },
            {
                "domain": {
                    "id": "46",
                    "name": "Brand Category",
                    "description": "Categories within Brand Verticals that narrow down the scope of Brands"
                },
                "entity": {
                    "id": "781974596752773120",
                    "name": "Pharma"
                }
            },
            {
                "domain": {
                    "id": "47",
                    "name": "Brand",
                    "description": "Brands and Companies"
                },
                "entity": {
                    "id": "10032761422",
                    "name": "Pfizer"
                }
            }
        ],
        "conversation_id": 1396771068329799680,
        "created_at": "2021-05-24T10:12:28+00:00",
        "entities": {
            "urls": [
                {
                    "start": 203,
                    "end": 226,
                    "url": "https://t.co/WjR5yhrNdn",
                    "expanded_url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00528-6/fulltext#:~:text=Supporting%20a%20longer%2Dinterval%20immunisation,was%20significantly%20higher%20at%2081&text=3%25%20(60&text=3%E2%80%9391&text=2)%20after%20two%20standard%20doses,or%20longer%2C%20compared%20with%2055",
                    "display_url": "thelancet.com/journals/lance\u2026",
                    "images": [
                        {
                            "url": "https://pbs.twimg.com/news_img/1454565484016201729/xl4VQcyz?format=jpg&name=orig",
                            "width": 181,
                            "height": 262
                        },
                        {
                            "url": "https://pbs.twimg.com/news_img/1454565484016201729/xl4VQcyz?format=jpg&name=150x150",
                            "width": 150,
                            "height": 150
                        }
                    ],
                    "status": 200,
                    "title": "Single-dose Oxford\u2013AstraZeneca COVID-19 vaccine followed by a 12-week booster",
                    "description": "Vaccines to prevent COVID-19 infection are crucial for an effective global pandemic response. In The Lancet, Merryn Voysey and colleagues1 report the updated primary efficacy results for the Oxford\u2013AstraZeneca ChAdOx1 nCoV-19 (AZD1222) vaccine from three single-blind, randomised controlled trials in the UK and Brazil and one double-blind study in South Africa.2\u20134 The ChAdOx1 nCoV-19 vaccine was granted emergency use authorisation in adults by the UK Medicines and Healthcare products Regulatory Agency5 in December, 2020.",
                    "unwound_url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00528-6/fulltext#:~:text=Supporting%20a%20longer%2Dinterval%20immunisation,was%20significantly%20higher%20at%2081&text=3%25%20(60&text=3%E2%80%9391&text=2)%20after%20two%20standard%20doses,or%20longer%2C%20compared%20with%2055"
                },
                {
                    "start": 227,
                    "end": 250,
                    "url": "https://t.co/VDPC83vHuQ",
                    "expanded_url": "https://twitter.com/rupasubramanya/status/1396503735107559425",
                    "display_url": "twitter.com/rupasubramanya\u2026"
                }
            ],
            "annotations": [
                {
                    "start": 42,
                    "end": 43,
                    "probability": 0.5203,
                    "type": "Place",
                    "normalized_text": "AZ"
                }
            ]
        },
        "geo": null,
        "in_reply_to_user_id": null,
        "lang": "en",
        "non_public_metrics": null,
        "organic_metrics": null,
        "possibly_sensitive": false,
        "promoted_metrics": null,
        "public_metrics": {
            "retweet_count": 0,
            "reply_count": 1,
            "like_count": 0,
            "quote_count": 0
        },
        "referenced_tweets": [
            {
                "data": {
                    "type": "quoted",
                    "id": "1396503735107559425"
                },
                "id": 1396503735107559425,
                "type": "quoted"
            }
        ],
        "reply_settings": "everyone",
        "source": "Twitter Web App",
        "withheld": null
    },
    {
        "data": {
            "entities": {
                "urls": [
                    {
                        "start": 46,
                        "end": 69,
                        "url": "https://t.co/WixCnGykQL",
                        "expanded_url": "https://twitter.com/rupasubramanya/status/1396503735107559425",
                        "display_url": "twitter.com/rupasubramanya\u2026"
                    }
                ]
            },
            "id": "1396509171533553678",
            "context_annotations": [
                {
                    "domain": {
                        "id": "123",
                        "name": "Ongoing News Story",
                        "description": "Ongoing News Stories like 'Brexit'"
                    },
                    "entity": {
                        "id": "1220701888179359745",
                        "name": "COVID-19"
                    }
                },
                {
                    "domain": {
                        "id": "45",
                        "name": "Brand Vertical",
                        "description": "Top level entities that describe a Brands industry"
                    },
                    "entity": {
                        "id": "781974596740190208",
                        "name": "CPG"
                    }
                },
                {
                    "domain": {
                        "id": "46",
                        "name": "Brand Category",
                        "description": "Categories within Brand Verticals that narrow down the scope of Brands"
                    },
                    "entity": {
                        "id": "781974596752773120",
                        "name": "Pharma"
                    }
                },
                {
                    "domain": {
                        "id": "47",
                        "name": "Brand",
                        "description": "Brands and Companies"
                    },
                    "entity": {
                        "id": "10032761422",
                        "name": "Pfizer"
                    }
                }
            ],
            "public_metrics": {
                "retweet_count": 0,
                "reply_count": 0,
                "like_count": 0,
                "quote_count": 0
            },
            "created_at": "2021-05-23T16:51:47.000Z",
            "reply_settings": "everyone",
            "author_id": "1560668581",
            "source": "Twitter for Android",
            "text": "Imagine money spent by pfizer..\nEnd of story. https://t.co/WixCnGykQL",
            "referenced_tweets": [
                {
                    "type": "quoted",
                    "id": "1396503735107559425"
                }
            ],
            "lang": "en",
            "possibly_sensitive": false,
            "conversation_id": "1396509171533553678"
        },
        "id": 1396509171533553678,
        "text": "Imagine money spent by pfizer..\nEnd of story. https://t.co/WixCnGykQL",
        "attachments": null,
        "author_id": 1560668581,
        "context_annotations": [
            {
                "domain": {
                    "id": "123",
                    "name": "Ongoing News Story",
                    "description": "Ongoing News Stories like 'Brexit'"
                },
                "entity": {
                    "id": "1220701888179359745",
                    "name": "COVID-19"
                }
            },
            {
                "domain": {
                    "id": "45",
                    "name": "Brand Vertical",
                    "description": "Top level entities that describe a Brands industry"
                },
                "entity": {
                    "id": "781974596740190208",
                    "name": "CPG"
                }
            },
            {
                "domain": {
                    "id": "46",
                    "name": "Brand Category",
                    "description": "Categories within Brand Verticals that narrow down the scope of Brands"
                },
                "entity": {
                    "id": "781974596752773120",
                    "name": "Pharma"
                }
            },
            {
                "domain": {
                    "id": "47",
                    "name": "Brand",
                    "description": "Brands and Companies"
                },
                "entity": {
                    "id": "10032761422",
                    "name": "Pfizer"
                }
            }
        ],
        "conversation_id": 1396509171533553678,
        "created_at": "2021-05-23T16:51:47+00:00",
        "entities": {
            "urls": [
                {
                    "start": 46,
                    "end": 69,
                    "url": "https://t.co/WixCnGykQL",
                    "expanded_url": "https://twitter.com/rupasubramanya/status/1396503735107559425",
                    "display_url": "twitter.com/rupasubramanya\u2026"
                }
            ]
        },
        "geo": null,
        "in_reply_to_user_id": null,
        "lang": "en",
        "non_public_metrics": null,
        "organic_metrics": null,
        "possibly_sensitive": false,
        "promoted_metrics": null,
        "public_metrics": {
            "retweet_count": 0,
            "reply_count": 0,
            "like_count": 0,
            "quote_count": 0
        },
        "referenced_tweets": [
            {
                "data": {
                    "type": "quoted",
                    "id": "1396503735107559425"
                },
                "id": 1396503735107559425,
                "type": "quoted"
            }
        ],
        "reply_settings": "everyone",
        "source": "Twitter for Android",
        "withheld": null
    },
    {
        "data": {
            "entities": {
                "urls": [
                    {
                        "start": 19,
                        "end": 42,
                        "url": "https://t.co/Pr6FhhVJ08",
                        "expanded_url": "https://twitter.com/rupasubramanya/status/1396503735107559425",
                        "display_url": "twitter.com/rupasubramanya\u2026"
                    }
                ],
                "hashtags": [
                    {
                        "start": 0,
                        "end": 10,
                        "tag": "covid19sk"
                    },
                    {
                        "start": 11,
                        "end": 18,
                        "tag": "skpoli"
                    }
                ]
            },
            "id": "1396504582625374210",
            "context_annotations": [
                {
                    "domain": {
                        "id": "123",
                        "name": "Ongoing News Story",
                        "description": "Ongoing News Stories like 'Brexit'"
                    },
                    "entity": {
                        "id": "1220701888179359745",
                        "name": "COVID-19"
                    }
                },
                {
                    "domain": {
                        "id": "45",
                        "name": "Brand Vertical",
                        "description": "Top level entities that describe a Brands industry"
                    },
                    "entity": {
                        "id": "781974596740190208",
                        "name": "CPG"
                    }
                },
                {
                    "domain": {
                        "id": "46",
                        "name": "Brand Category",
                        "description": "Categories within Brand Verticals that narrow down the scope of Brands"
                    },
                    "entity": {
                        "id": "781974596752773120",
                        "name": "Pharma"
                    }
                },
                {
                    "domain": {
                        "id": "47",
                        "name": "Brand",
                        "description": "Brands and Companies"
                    },
                    "entity": {
                        "id": "10032761422",
                        "name": "Pfizer"
                    }
                }
            ],
            "public_metrics": {
                "retweet_count": 0,
                "reply_count": 0,
                "like_count": 0,
                "quote_count": 0
            },
            "created_at": "2021-05-23T16:33:32.000Z",
            "reply_settings": "everyone",
            "author_id": "1433167542",
            "source": "Twitter for iPhone",
            "text": "#covid19sk #skpoli https://t.co/Pr6FhhVJ08",
            "referenced_tweets": [
                {
                    "type": "quoted",
                    "id": "1396503735107559425"
                }
            ],
            "lang": "und",
            "possibly_sensitive": false,
            "conversation_id": "1396504582625374210"
        },
        "id": 1396504582625374210,
        "text": "#covid19sk #skpoli https://t.co/Pr6FhhVJ08",
        "attachments": null,
        "author_id": 1433167542,
        "context_annotations": [
            {
                "domain": {
                    "id": "123",
                    "name": "Ongoing News Story",
                    "description": "Ongoing News Stories like 'Brexit'"
                },
                "entity": {
                    "id": "1220701888179359745",
                    "name": "COVID-19"
                }
            },
            {
                "domain": {
                    "id": "45",
                    "name": "Brand Vertical",
                    "description": "Top level entities that describe a Brands industry"
                },
                "entity": {
                    "id": "781974596740190208",
                    "name": "CPG"
                }
            },
            {
                "domain": {
                    "id": "46",
                    "name": "Brand Category",
                    "description": "Categories within Brand Verticals that narrow down the scope of Brands"
                },
                "entity": {
                    "id": "781974596752773120",
                    "name": "Pharma"
                }
            },
            {
                "domain": {
                    "id": "47",
                    "name": "Brand",
                    "description": "Brands and Companies"
                },
                "entity": {
                    "id": "10032761422",
                    "name": "Pfizer"
                }
            }
        ],
        "conversation_id": 1396504582625374210,
        "created_at": "2021-05-23T16:33:32+00:00",
        "entities": {
            "urls": [
                {
                    "start": 19,
                    "end": 42,
                    "url": "https://t.co/Pr6FhhVJ08",
                    "expanded_url": "https://twitter.com/rupasubramanya/status/1396503735107559425",
                    "display_url": "twitter.com/rupasubramanya\u2026"
                }
            ],
            "hashtags": [
                {
                    "start": 0,
                    "end": 10,
                    "tag": "covid19sk"
                },
                {
                    "start": 11,
                    "end": 18,
                    "tag": "skpoli"
                }
            ]
        },
        "geo": null,
        "in_reply_to_user_id": null,
        "lang": "und",
        "non_public_metrics": null,
        "organic_metrics": null,
        "possibly_sensitive": false,
        "promoted_metrics": null,
        "public_metrics": {
            "retweet_count": 0,
            "reply_count": 0,
            "like_count": 0,
            "quote_count": 0
        },
        "referenced_tweets": [
            {
                "data": {
                    "type": "quoted",
                    "id": "1396503735107559425"
                },
                "id": 1396503735107559425,
                "type": "quoted"
            }
        ],
        "reply_settings": "everyone",
        "source": "Twitter for iPhone",
        "withheld": null
    }
]